Please note: AABB reserves the right to make updates to this program.
Wednesday, October 25, 2017
2:00 – 3:30 PM (ET) 7:00 – 8:30 PM (GMT)
Master Program Number: 17EL-163 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Physicians, Scientists, Technologists, Nurses, Managers/Supervisors, CEOs, CFOs, Medical Directors, Students/Fellows, Residents, Hospital Blood Banks
Teaching Level: Intermediate
Director/Moderator: Suchitra Pandey, MD, Senior Chief Medical Officer, Blood Systems, Inc. (Blood Centers of the Pacific), San Francisco, CA
Speakers: Sridhar Basavaraju, MD, Medical officer, Epidemiologist, Office of Blood, Organ, and Other Tissue Safety, Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA; Jay Menitove, MD, Former President/CEO and Medical Director, Community Blood Center, Kansas City, MO
After participating in this educational activity, participants should be able to:
- Describe the key parameters that were assessed in 2015 National Blood Collection and Utilization Survey.
- Explain the trend in RBC, platelet, and plasma collection and utilization based on survey data from the last 10 years.
- Review at least two potential impacts of the findings of the 2015 survey to the Blood Bank Community.
- Discuss the current model of the Blood Banking in the US and possible changes to this model in the future.
In June 2017, the AABB released the findings from the 2015 National Blood Collection and Utilization Survey (NBCUS) which provides detailed information about the blood collection and transfusion practices in the United States. The survey was completed by blood collection centers and hospital transfusion services. The findings showed that blood collection and utilization continued to trend down for red cells, plasma, and platelets. The survey also provided interesting data about donor demographics in the US and price information for the different products. In this program, the findings of the 2015 NBCUS will be reviewed in detail. Subsequently, an analysis of the impact of these results on the Blood Bank industry will be provided and the long-term outlook for the current model of blood collection in the US will be reviewed.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||
Sridhar Basavaraju, MD is medical officer and Director of the CDC Office of Blood, Organ, and Other Tissue Safety. He joined the CDC in 2007 as an Epidemic Intelligence Service Officer after completing residency in Emergency Medicine at Mt. Sinai School of Medicine. Since 2007, he has worked at CDC on blood safety-related issues, first with the Division of Global HIV/AIDS as part of the U.S. President’s Emergency Plan for AIDS Relief and subsequently with the Office of Blood, Organ, and Other Tissue Safety. His office is responsible for investigating transfusion and transplant-transmitted infections and conducts the NBCUS through an inter-agency agreement with the Office of the Assistant Secretary for Health and Human Services.
Jay Menitove, MD, the former CEO/Medical Director of the Community Blood Center of Greater Kansas City, is a Clinical Professor of Pathology and Laboratory Medicine at the Kansas University Medical Center. He is board certified in internal medicine, hematology, and blood banking. He serves as an Associate Editor of TRANSFUSION, Chairs the HHS Advisory Committee on Blood and Tissue Safety and Availability, and is an AABB past-president. Dr. Menitove’s academic interests include transfusion safety, blood donation, and sustainability of the U.S. blood system. Recently, he provided consultations assisting hospitals seeking blood management and patient outcome improvements. He is the author or co-author of more than 150 journal articles, textbook chapters, and other publications.